CD133+ liver cancer cells showed more powerful capacity in proliferation than CD133− liver cancer cells, and higher levels of pAKT were identified in CD133+ cancer cells than in CD133− cancer cell [19–21]. This evidence concerns the gene PROM1 and cancer.